Belmont Global Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Belmont Global Advisors’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1.15M	Buy	+425,000	New	+$1.08M	1.09%	17

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

FPC

Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Belmont Global Advisors's BDSI Position: Q3 2016 in Review

Belmont Global Advisors opened a new position in BioDelivery Sciences International, Inc. (BDSI) in Q3 2016: 425,000 shares worth $1.15M. The stake represents 1.09% of the portfolio and ranks #17 among its holdings.

85 funds tracked by Wall St. Rank hold BDSI as of Q3 2016.

Belmont Global Advisors held 425,000 shares of BioDelivery Sciences International, Inc. worth $1.15M as of Q3 2016.
BioDelivery Sciences International, Inc. was a new Belmont Global Advisors position in Q3 2016.
BioDelivery Sciences International, Inc. made up 1.09% of Belmont Global Advisors's portfolio in Q3 2016, its #17 holding.
85 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2016.

Based on Belmont Global Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.